Related Experiment Video

Updated: Mar 31, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.7K

Polymicrobial community-acquired pneumonia: An emerging entity

Catia Cillóniz1, Rok Civljak2, Antonello Nicolini3

  • 1Department of Pneumology, Thorax Institute, Hospital Clinic of Barcelona-August Pi i Sunyer Biomedical Research Institute (IDIBAPS), University of Barcelona (UB)-SGR 911-, Ciber de Enfermedades Respiratorias (Ciberes), Barcelona, Spain.

Respirology (Carlton, Vic.)
|October 24, 2015
PubMed

Insights

Polymicrobial community-acquired pneumonia (CAP) is increasingly recognized, impacting patient immunity and outcomes. Current diagnostic methods often underestimate its true incidence, necessitating new therapeutic strategies.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Pulmonology

Background:

  • Polymicrobial etiology in community-acquired pneumonia (CAP) is increasingly prevalent.
  • This complex interaction influences host immunity, inflammation, and clinical outcomes in CAP patients.
  • Underestimation of polymicrobial CAP is likely due to diagnostic limitations.

Purpose of the Study:

  • To review the pathogenesis of polymicrobial CAP.
  • To discuss microbial interactions within the context of pneumonia.
  • To explore epidemiology, biomarkers, and antibiotic therapy for polymicrobial CAP.

Main Methods:

  • Literature review of polymicrobial community-acquired pneumonia.
  • Analysis of pathogenesis and microbial interactions.
  • Examination of epidemiological data and diagnostic challenges.

Main Results:

  • Polymicrobial infections are a significant, often underestimated, cause of CAP.
  • Diagnostic sensitivity and specimen availability limit accurate incidence determination.
  • The prevalence of polymicrobial CAP may necessitate revised antibiotic treatment guidelines.

Conclusions:

  • Polymicrobial CAP presents a complex clinical challenge.
  • Improved diagnostic tools are needed to accurately identify polymicrobial etiologies.
  • Further research into microbial interactions and targeted therapies is crucial for optimizing patient care.
Keywords:
community-acquired pneumoniainfectionmixedpneumoniapolymicrobial

More Related Videos

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes03:53

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes

Published on: April 19, 2024

1.3K
Tools for the Real-Time Assessment of a Pseudomonas aeruginosa Infection Model07:39

Tools for the Real-Time Assessment of a Pseudomonas aeruginosa Infection Model

Published on: April 6, 2021

4.3K

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.3K
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
38
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.2K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.1K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
4.1K
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
4.0K